Bright Minds Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 20, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019
Market Capitalization	379	8	28	107	-	-
Market Cap Growth	-59.17%	-71.17%	-73.71%	-	-	-
Enterprise Value	373	0	19	85	-	-
Last Close Price	54.54	2.15	8.50	45.20	-	-
PB Ratio	39.92	1.23	2.67	5.51	-	-
P/TBV Ratio	1.01	1.23	2.67	5.51	-	-
Debt / Equity Ratio	0.00	0.01	0.01	-	-	-
Quick Ratio	34.75	24.16	8.00	31.12	5.30	2.18
Current Ratio	35.08	24.26	8.11	31.38	5.82	2.18
Return on Equity (ROE)	-51.80%	-86.02%	-99.95%	-85.94%	-124.04%	-
Return on Assets (ROA)	-28.86%	-47.45%	-57.32%	-51.52%	-61.70%	-
Return on Capital (ROIC)	-30.53%	-51.86%	-61.21%	-53.54%	-76.64%	-
Earnings Yield	-1.59%	-90.90%	-53.20%	-8.09%	-	-
FCF Yield	-41.96%	-86.61%	-48.30%	-6.84%	-	-
Buyback Yield / Dilution	-19.17%	-50.57%	-37.64%	-148.42%	-74.24%	-
Total Shareholder Return	-19.17%	-50.57%	-37.64%	-148.42%	-74.24%	-

Source: S&P Capital IQ. Standard template. Financial Sources.